Dr. Jun Gong, MD
Claim this profileCedars-Sinai Medical Center
Studies Colorectal Cancer
Studies Cancer
18 reported clinical trials
35 drugs studied
About Jun Gong, MD
Education:
- Earned an MD from New York Medical College in 2008.
- Completed Internship and Residency at Cedars-Sinai Medical Center by 2013.
- Undertook a Fellowship at City of Hope Comprehensive Cancer Center in 2015.
Experience:
- Board-certified in Internal Medicine/Hematology, General Internal Medicine, and Internal Medicine/Oncology by the American Board of Internal Medicine.
- Has 15 years of experience as a medical oncologist and researcher at Cedars-Sinai Medical Center.
- Specializes in gastrointestinal and neuroendocrine malignancies, as well as urologic oncology.
Area of expertise
1Colorectal Cancer
Stage IV
BRAF negative
Stage III
2Cancer
Stage IV
p16 positive
KRAS negative
Affiliated Hospitals
Clinical Trials Jun Gong, MD is currently running
Apalutamide + Carotuximab
for Prostate Cancer
This is an open-label, multi-site study of apalutamide with carotuximab in patients who have progressed on androgen receptor signaling inhibitor (ARSI) therapy. This study will begin with a safety assessment in the first 10 subjects (part 1: Safety Lead-in). If the combination is deemed safe, the trial will proceed to the Phase II stage. The purpose of this study is to compare progression free survival (PFS) between patients receiving apalutamide and apalutamide + carotuximab using Response Evaluation Criteria in Solid Tumors (RECIST 1.1) and Prostate Cancer Working Group 3. The secondary objectives are to describe adverse events related to the intervention, overall response rate (ORR), proportion of patients resistant to apalutamide that benefit from the addition of carotuximab, and to determine the ORR, radiographic PFS, and biochemical PFS in the overall population.
Recruiting1 award Phase 2
Oral Ketamine
for Anxiety in Pancreatic Cancer Patients
This is a prospective, single center, double blind, randomized, crossover feasibility study of oral ketamine versus placebo for the treatment of anxiety in patients with pancreatic cancer currently receiving or within 12 weeks of receiving cancer targeted therapy. The primary objective is to determine the feasibility of enrolling subjects and treatment adherence. The secondary objectives are to describe the safety and tolerability. Exploratory objectives are to assess the effect of ketamine/placebo on Depression, Anxiety, Physical Function, Pain Interference, Pain Intensity, Fatigue, Sleep Disturbance, and Ability to Participate in Social Roles and Activities as measured by PROMIS Anxiety Short Form 7a and the PROMIS-29 Profile v2.1 of Patient Reported Outcomes, as well as changes in circulatory inflammatory cytokines, blood glutamine levels, and other biomarkers of anxiety and/or depression.
Recruiting0 awards Phase < 111 criteria
More about Jun Gong, MD
Clinical Trial Related3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Jun Gong, MD has experience with
- Ketorolac Tromethamine
- Pancrelipase
- Wearable Activity Monitor
- Telatinib
- Keytruda
- Placebo
Breakdown of trials Jun Gong, MD has run
Colorectal Cancer
Cancer
Adenocarcinoma
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jun Gong, MD specialize in?
Jun Gong, MD focuses on Colorectal Cancer and Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are BRAF negative.
Is Jun Gong, MD currently recruiting for clinical trials?
Yes, Jun Gong, MD is currently recruiting for 7 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Jun Gong, MD has studied deeply?
Yes, Jun Gong, MD has studied treatments such as Ketorolac Tromethamine, Pancrelipase, Wearable activity monitor.
What is the best way to schedule an appointment with Jun Gong, MD?
Apply for one of the trials that Jun Gong, MD is conducting.
What is the office address of Jun Gong, MD?
The office of Jun Gong, MD is located at: Cedars-Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars-Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.